number2

Pharma in review: trending stories 10/11/19

Oct. 11, 2019

Glenmark receives FDA warning letter for Baddi plant

Mumbai-based Glenmark has been issued a FDA warning letter for manufacturing issues.

Pfizer inks antisense drug deal worth up to $1.5B
Pfizer will front $250 million to gain rights to a phase 2 drug.

Jury awards man $8B for claims a J&J drug made him grow breasts

A jury has ordered J& to pay $8 billion for a claim that the company failed to warn patients.

Universities took millions in gifts from Sackler family

Universities around the world have accepted at least $60 million in donations over the past five years.

How to find the right CDMO partner 

A couple of deciding factors remain constant industry-wide